ArticleTranslational cancer research2024
Robot-assisted radical prostatectomy using the novel hinotori
Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysis.Prostate cancer and prostatic diseases · 2026Pooled it
- Comparison of the Hinotori surgical robot with the da Vinci robotic system in urologic surgery: a systematic review and meta-analysis.Journal of robotic surgery · 2025Pooled it
- Comparison of perioperative outcomes and prognosis between Da Vinci surgical system and Hinotori system in urologic tumor surgery: evidence from controlled trials.Journal of robotic surgery · 2025Pooled it
- Comparison of the Hinotori surgical robot with the da Vinci robotic system in radical prostatectomy: a systematic review and meta-analysis.Journal of robotic surgery · 2025Pooled it
- Robotic abdominopelvic surgery: a systematic review of cross-platform outcomes.Journal of robotic surgery · 2024Pooled it
- Article
- Cumulative institutional experience and console time in robot-assisted right-sided colectomy: a single-center experience with two sequentially introduced robotic platforms.Surgical endoscopy · 2026Article
- Hinotori vs. da Vinci: a multi-institutional study on robot-assisted radical prostatectomy outcomes.Journal of robotic surgery · 2026Article
- Review
- Comparison of the da Vinci Xi and hinotori surgical robotic systems using a training model: an ex vivo study.Journal of robotic surgery · 2026Article
- Application Effect of Different Robotic Surgery Systems in Radical Prostatectomy: A Comparative Study Based on a Network Meta-analysis.European urology open science · 2025Review
- Beyond Da Vinci: Comparative Review of Next-Generation Robotic Platforms in Urologic Surgery.Journal of clinical medicine · 2025Review
- Comparison of Perioperative Outcomes for Complex Renal Tumors Between the Da Vinci and Hinotori Surgical Robot System During Robot-Assisted Partial Nephrectomy: A Propensity Score Matching Analysis.Journal of clinical medicine · 2025Article
- Article
- Article
- Feasibility of the hinotori™ surgical robot system in right colectomy: a propensity score matching study.Surgical endoscopy · 2025Article
- Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis.European urology open science · 2025Review
- The usefulness of Hinotori™ which is a surgical support robot system developed in Japan and a challenging case of robot-assisted surgery.Translational cancer research · 2024Article
- Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review.Journal of clinical medicine · 2024Review
- Evaluation of Clinical Research on Novel Multiport Robotic Platforms for Urological Surgery According to the IDEAL Framework: A Systematic Review of the Literature.European urology open science · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The hinotori Methods: Between November 2021 and December 2022, 97 patients who underwent h-RARP at our institution were enrolled in this study. We retrospectively evaluated the surgical outcomes of the initial cases using h-RARP, comparing those of RARP using da Vinci surgical robot system (d-RARP) in our institution. Furthermore, the learning curves of two surgeons with the highest number of h-RARP were analyzed. Patients treated by each surgeon were categorized into two groups: 1-15 cases (earlier group) and >15 cases (later group). Preoperative patient characteristics, operation parameters, and complication rates were compared between the two groups. Results: In terms of surgical outcome, h-RARP was comparable to d-RARP. The procedures performed by the HSRS were successfully completed in all cases. There was no complication of grade 3 or higher. Comparing the two surgeons, surgeon 1, who had performed 40 d-RARP procedures, had time using robot system of the later group that was significantly shorter than that of the earlier group. However, for surgeon 2 with more than 100 d-RARP procedures, there was no statistically significant difference in time using robot system between groups. Other parameters showed no difference between earlier and later groups for the two surgeons. Conclusions: Our results show that surgical outcomes of h-RARP are comparable to those of d-RARP during the initial experience of clinical application. In addition, the surgeons' learning curves for the total RARP experience suggest that the experience of d-RARP can carry over to performance using the novel HSRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.